 Csaba Galambos
Concepts (473)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Alveoli | 15 | 2023 | 384 | 3.110 |
Why?
| | Persistent Fetal Circulation Syndrome | 9 | 2023 | 132 | 2.840 |
Why?
| | Lung | 29 | 2023 | 3664 | 2.720 |
Why?
| | Pulmonary Artery | 11 | 2021 | 1063 | 2.550 |
Why?
| | Respiratory Insufficiency | 5 | 2023 | 290 | 2.420 |
Why?
| | Pulmonary Veins | 5 | 2019 | 84 | 1.970 |
Why?
| | Arteriovenous Anastomosis | 4 | 2022 | 13 | 1.840 |
Why?
| | Bronchial Arteries | 3 | 2018 | 11 | 1.840 |
Why?
| | Bronchi | 6 | 2023 | 242 | 1.660 |
Why?
| | Down Syndrome | 6 | 2021 | 356 | 1.380 |
Why?
| | Pulmonary Circulation | 7 | 2022 | 424 | 1.360 |
Why?
| | Hypertension, Pulmonary | 14 | 2022 | 1794 | 1.350 |
Why?
| | Glycogen Storage Disease | 4 | 2021 | 21 | 1.280 |
Why?
| | Infant, Newborn | 34 | 2023 | 5255 | 1.150 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2023 | 193 | 1.140 |
Why?
| | T-Box Domain Proteins | 3 | 2023 | 95 | 1.120 |
Why?
| | Immunohistochemistry | 13 | 2017 | 1691 | 1.110 |
Why?
| | Lung Diseases, Interstitial | 6 | 2021 | 464 | 1.100 |
Why?
| | Homeodomain Proteins | 4 | 2017 | 468 | 1.100 |
Why?
| | Infant | 36 | 2023 | 8293 | 1.070 |
Why?
| | Abnormalities, Multiple | 3 | 2016 | 181 | 1.000 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 325 | 1.000 |
Why?
| | Heart Defects, Congenital | 6 | 2022 | 703 | 0.950 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 3 | 2014 | 55 | 0.920 |
Why?
| | Lymphatic Vessels | 3 | 2009 | 54 | 0.910 |
Why?
| | Lung Diseases | 7 | 2021 | 718 | 0.910 |
Why?
| | Germ-Line Mutation | 1 | 2023 | 134 | 0.880 |
Why?
| | Cardiovascular Abnormalities | 1 | 2022 | 12 | 0.870 |
Why?
| | Sudden Infant Death | 1 | 2022 | 25 | 0.870 |
Why?
| | Capillaries | 3 | 2014 | 103 | 0.820 |
Why?
| | Humans | 87 | 2023 | 118974 | 0.760 |
Why?
| | Graft Rejection | 5 | 2013 | 555 | 0.710 |
Why?
| | Mutation | 12 | 2023 | 3457 | 0.710 |
Why?
| | Tumor Suppressor Proteins | 3 | 2011 | 289 | 0.710 |
Why?
| | Child, Preschool | 25 | 2021 | 9491 | 0.700 |
Why?
| | Histological Techniques | 2 | 2009 | 43 | 0.690 |
Why?
| | Death, Sudden | 1 | 2019 | 33 | 0.680 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2009 | 140 | 0.680 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 3 | 2014 | 82 | 0.660 |
Why?
| | Fatal Outcome | 7 | 2019 | 287 | 0.650 |
Why?
| | Pneumonia | 2 | 2022 | 592 | 0.640 |
Why?
| | Child | 36 | 2023 | 19129 | 0.630 |
Why?
| | Gene Deletion | 1 | 2019 | 361 | 0.620 |
Why?
| | Pneumonia, Lipid | 1 | 2017 | 3 | 0.620 |
Why?
| | Imaging, Three-Dimensional | 4 | 2019 | 499 | 0.600 |
Why?
| | Virus Diseases | 2 | 2009 | 198 | 0.590 |
Why?
| | Airway Obstruction | 1 | 2019 | 168 | 0.580 |
Why?
| | Collagen Type VIII | 1 | 2016 | 2 | 0.580 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2016 | 7 | 0.580 |
Why?
| | Collagen Type IV | 1 | 2016 | 22 | 0.570 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2016 | 55 | 0.570 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2015 | 11 | 0.550 |
Why?
| | Veins | 1 | 2016 | 60 | 0.540 |
Why?
| | Male | 48 | 2023 | 57801 | 0.540 |
Why?
| | Anemia, Sickle Cell | 1 | 2019 | 230 | 0.540 |
Why?
| | Microvessels | 1 | 2016 | 77 | 0.530 |
Why?
| | Sarcoma | 1 | 2017 | 137 | 0.530 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2017 | 181 | 0.520 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2014 | 189 | 0.500 |
Why?
| | Arteriovenous Fistula | 1 | 2014 | 29 | 0.500 |
Why?
| | Hypoxia | 2 | 2019 | 963 | 0.490 |
Why?
| | Female | 43 | 2022 | 61565 | 0.490 |
Why?
| | Transcription Factors | 3 | 2023 | 1570 | 0.470 |
Why?
| | Nuclear Proteins | 2 | 2010 | 597 | 0.460 |
Why?
| | Autoantigens | 1 | 2016 | 397 | 0.460 |
Why?
| | Lymphangiogenesis | 2 | 2011 | 23 | 0.450 |
Why?
| | Vascular Endothelial Growth Factor Receptor-3 | 2 | 2009 | 6 | 0.440 |
Why?
| | Tomography, X-Ray Computed | 8 | 2022 | 2436 | 0.440 |
Why?
| | ABO Blood-Group System | 2 | 2011 | 35 | 0.440 |
Why?
| | Endothelium, Lymphatic | 3 | 2009 | 12 | 0.440 |
Why?
| | Antibodies, Monoclonal | 3 | 2009 | 1284 | 0.430 |
Why?
| | Complement C4b | 2 | 2013 | 10 | 0.430 |
Why?
| | Sensitivity and Specificity | 6 | 2017 | 1795 | 0.410 |
Why?
| | Heart Neoplasms | 2 | 2022 | 50 | 0.400 |
Why?
| | Diagnosis, Differential | 8 | 2017 | 1384 | 0.390 |
Why?
| | Biomarkers | 7 | 2020 | 3588 | 0.380 |
Why?
| | Erythema | 1 | 2010 | 24 | 0.380 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1059 | 0.380 |
Why?
| | Phosphoproteins | 2 | 2018 | 308 | 0.380 |
Why?
| | Vena Cava, Superior | 1 | 2010 | 21 | 0.380 |
Why?
| | Forkhead Transcription Factors | 3 | 2023 | 182 | 0.370 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2010 | 35 | 0.370 |
Why?
| | Scalp | 2 | 2010 | 29 | 0.360 |
Why?
| | Vena Cava, Inferior | 1 | 2010 | 55 | 0.360 |
Why?
| | Ranula | 1 | 2009 | 3 | 0.350 |
Why?
| | Mucocele | 1 | 2009 | 11 | 0.350 |
Why?
| | Pleural Effusion | 2 | 2021 | 47 | 0.350 |
Why?
| | Pathology | 1 | 2009 | 20 | 0.340 |
Why?
| | Asthma | 2 | 2021 | 2158 | 0.340 |
Why?
| | Hemodynamics | 5 | 2021 | 1004 | 0.340 |
Why?
| | Blood Group Antigens | 1 | 2009 | 16 | 0.340 |
Why?
| | Vascular Malformations | 1 | 2009 | 47 | 0.330 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 2 | 2021 | 41 | 0.320 |
Why?
| | Cryopreservation | 1 | 2009 | 99 | 0.320 |
Why?
| | Adolescent | 16 | 2020 | 18480 | 0.320 |
Why?
| | Viruses | 1 | 2009 | 96 | 0.310 |
Why?
| | Endocardium | 1 | 2007 | 31 | 0.310 |
Why?
| | Peptide Fragments | 2 | 2013 | 702 | 0.310 |
Why?
| | Phenotype | 5 | 2023 | 3003 | 0.310 |
Why?
| | Heart Transplantation | 3 | 2013 | 671 | 0.310 |
Why?
| | Hemorrhage | 2 | 2021 | 623 | 0.300 |
Why?
| | Infant, Premature | 3 | 2023 | 480 | 0.290 |
Why?
| | Young Adult | 7 | 2023 | 10793 | 0.290 |
Why?
| | Temporal Muscle | 1 | 2005 | 2 | 0.280 |
Why?
| | Heart Ventricles | 4 | 2022 | 727 | 0.270 |
Why?
| | Vascular Resistance | 2 | 2019 | 356 | 0.270 |
Why?
| | Choristoma | 1 | 2005 | 24 | 0.270 |
Why?
| | Thyroid Nuclear Factor 1 | 2 | 2019 | 13 | 0.270 |
Why?
| | Herpesvirus 8, Human | 1 | 2006 | 68 | 0.270 |
Why?
| | Lymphatic Vessel Tumors | 1 | 2005 | 1 | 0.260 |
Why?
| | Neovascularization, Physiologic | 1 | 2007 | 181 | 0.260 |
Why?
| | Disease Models, Animal | 6 | 2019 | 3730 | 0.260 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 369 | 0.260 |
Why?
| | Synchrotrons | 2 | 2021 | 9 | 0.250 |
Why?
| | Microscopy, Phase-Contrast | 2 | 2021 | 19 | 0.250 |
Why?
| | X-Ray Microtomography | 2 | 2021 | 79 | 0.240 |
Why?
| | Soft Tissue Neoplasms | 1 | 2005 | 93 | 0.240 |
Why?
| | Lung Transplantation | 2 | 2019 | 263 | 0.230 |
Why?
| | Hemangiopericytoma | 1 | 2003 | 3 | 0.230 |
Why?
| | Aorta | 2 | 2019 | 367 | 0.230 |
Why?
| | Infant Death | 1 | 2022 | 4 | 0.220 |
Why?
| | Biopsy | 8 | 2022 | 1079 | 0.220 |
Why?
| | Arteriovenous Malformations | 1 | 2022 | 24 | 0.220 |
Why?
| | Fibrin | 1 | 2023 | 60 | 0.220 |
Why?
| | Severity of Illness Index | 5 | 2018 | 2674 | 0.220 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 55 | 0.220 |
Why?
| | Fibroma | 1 | 2022 | 20 | 0.210 |
Why?
| | Antibodies, Viral | 1 | 2006 | 542 | 0.210 |
Why?
| | Lymphokines | 1 | 2002 | 122 | 0.210 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 48 | 0.210 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2022 | 36 | 0.210 |
Why?
| | Myocardium | 2 | 2017 | 970 | 0.200 |
Why?
| | Cell Proliferation | 4 | 2019 | 2275 | 0.200 |
Why?
| | Epilepsy | 1 | 2005 | 290 | 0.200 |
Why?
| | Sjogren's Syndrome | 1 | 2021 | 40 | 0.200 |
Why?
| | Vascular Remodeling | 2 | 2021 | 152 | 0.200 |
Why?
| | Protein C | 1 | 2021 | 44 | 0.200 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 19 | 0.190 |
Why?
| | Vasculitis | 1 | 2021 | 75 | 0.190 |
Why?
| | Adult | 9 | 2023 | 31512 | 0.180 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 93 | 0.180 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 200 | 0.180 |
Why?
| | Renal Insufficiency | 1 | 2021 | 150 | 0.180 |
Why?
| | Pulmonary Heart Disease | 1 | 2019 | 6 | 0.180 |
Why?
| | Athetosis | 1 | 2019 | 8 | 0.170 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2019 | 20 | 0.170 |
Why?
| | Chorea | 1 | 2019 | 12 | 0.170 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 12 | 0.170 |
Why?
| | Retrospective Studies | 9 | 2021 | 12978 | 0.170 |
Why?
| | Mitochondrial Diseases | 1 | 2020 | 79 | 0.170 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2018 | 14 | 0.170 |
Why?
| | Heterozygote | 1 | 2019 | 262 | 0.170 |
Why?
| | Pulmonary Eosinophilia | 1 | 2018 | 25 | 0.170 |
Why?
| | Silicosis | 1 | 2018 | 21 | 0.170 |
Why?
| | Exodeoxyribonucleases | 1 | 2018 | 22 | 0.170 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2018 | 19 | 0.160 |
Why?
| | DNA Copy Number Variations | 1 | 2019 | 167 | 0.160 |
Why?
| | Catheterization, Swan-Ganz | 1 | 2018 | 8 | 0.160 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 215 | 0.160 |
Why?
| | Stenosis, Pulmonary Artery | 1 | 2018 | 4 | 0.160 |
Why?
| | Nervous System Malformations | 1 | 2018 | 33 | 0.160 |
Why?
| | Mice, Knockout | 1 | 2004 | 2680 | 0.160 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 101 | 0.160 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2018 | 83 | 0.160 |
Why?
| | Histiocytosis | 1 | 2017 | 8 | 0.160 |
Why?
| | Gene Expression | 1 | 2023 | 1489 | 0.160 |
Why?
| | Multiple Myeloma | 1 | 2019 | 100 | 0.160 |
Why?
| | Heart Failure | 3 | 2021 | 1969 | 0.160 |
Why?
| | Macrophages, Alveolar | 2 | 2012 | 359 | 0.160 |
Why?
| | Contracture | 1 | 2017 | 23 | 0.150 |
Why?
| | Macrophage Activation Syndrome | 1 | 2017 | 12 | 0.150 |
Why?
| | Early Medical Intervention | 1 | 2018 | 56 | 0.150 |
Why?
| | Pleurisy | 1 | 2017 | 6 | 0.150 |
Why?
| | Uremia | 1 | 2017 | 18 | 0.150 |
Why?
| | Coccyx | 1 | 2017 | 5 | 0.150 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 6 | 0.150 |
Why?
| | Arthritis, Juvenile | 1 | 2017 | 42 | 0.150 |
Why?
| | Anti-Asthmatic Agents | 1 | 2021 | 343 | 0.150 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2017 | 60 | 0.150 |
Why?
| | Membrane Proteins | 1 | 2023 | 1055 | 0.150 |
Why?
| | Up-Regulation | 2 | 2020 | 872 | 0.150 |
Why?
| | Developmental Disabilities | 1 | 2020 | 247 | 0.150 |
Why?
| | Collagen Type XVIII | 1 | 2016 | 5 | 0.150 |
Why?
| | Syndrome | 2 | 2010 | 344 | 0.140 |
Why?
| | Sacrum | 1 | 2017 | 67 | 0.140 |
Why?
| | Myocardial Contraction | 1 | 2018 | 339 | 0.140 |
Why?
| | Kidney | 2 | 2022 | 1353 | 0.140 |
Why?
| | Killer Cells, Natural | 1 | 2019 | 381 | 0.140 |
Why?
| | Teratoma | 1 | 2017 | 92 | 0.140 |
Why?
| | Cadaver | 2 | 2015 | 327 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 540 | 0.140 |
Why?
| | Autopsy | 1 | 2016 | 89 | 0.140 |
Why?
| | Ventricular Function, Right | 1 | 2018 | 257 | 0.140 |
Why?
| | Pancreatic Neoplasms | 1 | 2003 | 734 | 0.140 |
Why?
| | Cell Transdifferentiation | 1 | 2015 | 32 | 0.130 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2015 | 53 | 0.130 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 93 | 0.130 |
Why?
| | Carrier Proteins | 1 | 2020 | 726 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2021 | 3171 | 0.130 |
Why?
| | Marijuana Smoking | 1 | 2018 | 220 | 0.130 |
Why?
| | Pancreatic Ducts | 1 | 2015 | 66 | 0.130 |
Why?
| | Down-Regulation | 1 | 2017 | 627 | 0.130 |
Why?
| | Muscle Proteins | 1 | 2016 | 219 | 0.130 |
Why?
| | Bone Neoplasms | 1 | 2017 | 199 | 0.130 |
Why?
| | Pregnancy | 4 | 2019 | 5691 | 0.120 |
Why?
| | Algorithms | 1 | 2022 | 1541 | 0.120 |
Why?
| | Adventitia | 1 | 2014 | 39 | 0.120 |
Why?
| | Alanine Transaminase | 2 | 2013 | 152 | 0.120 |
Why?
| | Hepatic Veno-Occlusive Disease | 1 | 2013 | 10 | 0.120 |
Why?
| | Genetic Variation | 1 | 2019 | 926 | 0.120 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 770 | 0.120 |
Why?
| | Macaca fascicularis | 1 | 2013 | 53 | 0.120 |
Why?
| | Radiation Injuries, Experimental | 1 | 2013 | 24 | 0.120 |
Why?
| | I-kappa B Proteins | 1 | 2014 | 80 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2016 | 404 | 0.120 |
Why?
| | Brain | 1 | 2005 | 2490 | 0.120 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2016 | 344 | 0.120 |
Why?
| | Adenofibroma | 1 | 2013 | 2 | 0.120 |
Why?
| | Animals | 12 | 2023 | 33381 | 0.110 |
Why?
| | Mucin-5B | 1 | 2015 | 175 | 0.110 |
Why?
| | Infant, Extremely Premature | 1 | 2013 | 58 | 0.110 |
Why?
| | Hyperoxia | 1 | 2014 | 97 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1390 | 0.110 |
Why?
| | Gene Expression Profiling | 2 | 2016 | 1597 | 0.110 |
Why?
| | Hepatocytes | 1 | 2013 | 205 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2015 | 613 | 0.110 |
Why?
| | Osteopetrosis | 1 | 2012 | 2 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2013 | 138 | 0.110 |
Why?
| | Mandibular Neoplasms | 1 | 2012 | 22 | 0.110 |
Why?
| | Vacuolar Proton-Translocating ATPases | 1 | 2012 | 14 | 0.110 |
Why?
| | Nephrectomy | 1 | 2013 | 162 | 0.100 |
Why?
| | Parasympathetic Nervous System | 1 | 2011 | 25 | 0.100 |
Why?
| | Burkitt Lymphoma | 1 | 2012 | 53 | 0.100 |
Why?
| | Blood Group Incompatibility | 1 | 2011 | 15 | 0.100 |
Why?
| | Glycogen Storage Disease Type III | 1 | 2011 | 1 | 0.100 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 330 | 0.100 |
Why?
| | Prognosis | 4 | 2021 | 3443 | 0.100 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 67 | 0.100 |
Why?
| | Lung Injury | 1 | 2014 | 210 | 0.100 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1774 | 0.100 |
Why?
| | Transplants | 1 | 2011 | 36 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 814 | 0.100 |
Why?
| | Transplantation, Homologous | 2 | 2011 | 415 | 0.100 |
Why?
| | Mannose-Binding Lectins | 1 | 2010 | 14 | 0.100 |
Why?
| | Sympathetic Nervous System | 1 | 2011 | 171 | 0.100 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2010 | 11 | 0.100 |
Why?
| | Lectins, C-Type | 1 | 2010 | 63 | 0.090 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2010 | 3 | 0.090 |
Why?
| | Antigens, CD1 | 1 | 2010 | 60 | 0.090 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2010 | 24 | 0.090 |
Why?
| | Thyroid Diseases | 1 | 2010 | 30 | 0.090 |
Why?
| | MicroRNAs | 1 | 2016 | 637 | 0.090 |
Why?
| | Multiple Organ Failure | 2 | 2012 | 150 | 0.090 |
Why?
| | NF-kappa B | 1 | 2014 | 670 | 0.090 |
Why?
| | Reference Values | 1 | 2011 | 774 | 0.090 |
Why?
| | Upper Extremity | 1 | 2010 | 81 | 0.090 |
Why?
| | Vascular Stiffness | 1 | 2014 | 425 | 0.090 |
Why?
| | Arthritis, Infectious | 1 | 2010 | 52 | 0.090 |
Why?
| | Islets of Langerhans | 1 | 2015 | 739 | 0.090 |
Why?
| | Tissue Preservation | 1 | 2009 | 13 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 1346 | 0.090 |
Why?
| | Immune Tolerance | 1 | 2011 | 334 | 0.090 |
Why?
| | Antigens, CD34 | 1 | 2009 | 98 | 0.090 |
Why?
| | Time Factors | 4 | 2019 | 6412 | 0.080 |
Why?
| | Sampling Studies | 1 | 2009 | 92 | 0.080 |
Why?
| | Disease Management | 1 | 2013 | 571 | 0.080 |
Why?
| | Kidney Neoplasms | 1 | 2013 | 334 | 0.080 |
Why?
| | Ki-67 Antigen | 1 | 2009 | 108 | 0.080 |
Why?
| | Histocompatibility Testing | 1 | 2009 | 123 | 0.080 |
Why?
| | Face | 1 | 2010 | 165 | 0.080 |
Why?
| | Brain Diseases | 1 | 2010 | 140 | 0.080 |
Why?
| | Papillomaviridae | 1 | 2009 | 101 | 0.080 |
Why?
| | Hip Joint | 1 | 2010 | 144 | 0.080 |
Why?
| | Acute Disease | 1 | 2011 | 940 | 0.080 |
Why?
| | Blood-Air Barrier | 1 | 2008 | 9 | 0.080 |
Why?
| | Adenoviridae | 1 | 2009 | 191 | 0.080 |
Why?
| | Cytomegalovirus | 1 | 2009 | 144 | 0.080 |
Why?
| | Middle Aged | 5 | 2016 | 27617 | 0.080 |
Why?
| | Antigens, CD | 1 | 2010 | 460 | 0.080 |
Why?
| | Paraffin Embedding | 1 | 2007 | 22 | 0.080 |
Why?
| | Pulmonary Valve | 1 | 2009 | 99 | 0.080 |
Why?
| | Hormones | 1 | 2008 | 135 | 0.080 |
Why?
| | Wound Healing | 1 | 2009 | 270 | 0.070 |
Why?
| | Lower Extremity | 1 | 2010 | 335 | 0.070 |
Why?
| | Fetal Death | 1 | 2006 | 52 | 0.070 |
Why?
| | Graft Survival | 1 | 2009 | 504 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2874 | 0.070 |
Why?
| | Insulin | 1 | 2015 | 2162 | 0.070 |
Why?
| | Liver | 1 | 2013 | 1816 | 0.070 |
Why?
| | Sequence Deletion | 2 | 2022 | 171 | 0.070 |
Why?
| | Fetal Development | 1 | 2008 | 250 | 0.060 |
Why?
| | Rhabdomyosarcoma | 1 | 2005 | 57 | 0.060 |
Why?
| | Specimen Handling | 1 | 2006 | 165 | 0.060 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2021 | 667 | 0.060 |
Why?
| | Fibrosis | 2 | 2017 | 483 | 0.060 |
Why?
| | Neuroglia | 1 | 2005 | 157 | 0.060 |
Why?
| | Sheep | 2 | 2019 | 764 | 0.060 |
Why?
| | Apoptosis | 1 | 2014 | 2484 | 0.060 |
Why?
| | Comorbidity | 2 | 2020 | 1527 | 0.060 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2004 | 165 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1868 | 0.060 |
Why?
| | Endothelial Cells | 2 | 2020 | 732 | 0.060 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 225 | 0.060 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2004 | 198 | 0.060 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 67 | 0.050 |
Why?
| | Mice | 4 | 2014 | 15520 | 0.050 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2022 | 13 | 0.050 |
Why?
| | Mouth Mucosa | 1 | 2022 | 82 | 0.050 |
Why?
| | Mosaicism | 1 | 2022 | 62 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2019 | 278 | 0.050 |
Why?
| | Leukemia, Megakaryoblastic, Acute | 1 | 2002 | 11 | 0.050 |
Why?
| | Models, Anatomic | 1 | 2002 | 94 | 0.050 |
Why?
| | Myeloproliferative Disorders | 1 | 2002 | 26 | 0.050 |
Why?
| | Plasma Cells | 1 | 2002 | 59 | 0.050 |
Why?
| | Lymphoproliferative Disorders | 1 | 2002 | 46 | 0.050 |
Why?
| | Meningeal Neoplasms | 1 | 2003 | 90 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2002 | 345 | 0.050 |
Why?
| | Heparin | 1 | 2002 | 230 | 0.050 |
Why?
| | Alternative Splicing | 1 | 2002 | 193 | 0.050 |
Why?
| | Indazoles | 1 | 2021 | 60 | 0.050 |
Why?
| | Cardiopulmonary Bypass | 1 | 2022 | 203 | 0.050 |
Why?
| | Surface-Active Agents | 1 | 2021 | 81 | 0.050 |
Why?
| | Bevacizumab | 1 | 2021 | 124 | 0.050 |
Why?
| | Granuloma | 1 | 2021 | 87 | 0.050 |
Why?
| | Risk Factors | 3 | 2020 | 9000 | 0.050 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2020 | 33 | 0.050 |
Why?
| | Age of Onset | 1 | 2021 | 467 | 0.040 |
Why?
| | Tumor Hypoxia | 1 | 2019 | 5 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 527 | 0.040 |
Why?
| | Risk Assessment | 1 | 2009 | 3057 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 53 | 0.040 |
Why?
| | Signal Transduction | 3 | 2019 | 4709 | 0.040 |
Why?
| | Coronary Occlusion | 1 | 2019 | 18 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 907 | 0.040 |
Why?
| | Interleukin-15 | 1 | 2019 | 77 | 0.040 |
Why?
| | Age Factors | 2 | 2016 | 2995 | 0.040 |
Why?
| | Homozygote | 1 | 2019 | 190 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 282 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 155 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2019 | 9342 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2019 | 99 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 48 | 0.040 |
Why?
| | Siblings | 1 | 2019 | 235 | 0.040 |
Why?
| | Nucleoside Transport Proteins | 1 | 2017 | 4 | 0.040 |
Why?
| | Tumor Burden | 1 | 2019 | 274 | 0.040 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 95 | 0.040 |
Why?
| | Pyrimidines | 1 | 2021 | 382 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2019 | 416 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1166 | 0.040 |
Why?
| | Azathioprine | 1 | 2017 | 51 | 0.040 |
Why?
| | Sulfonamides | 1 | 2021 | 445 | 0.040 |
Why?
| | Pleura | 1 | 2017 | 18 | 0.040 |
Why?
| | Age Distribution | 1 | 2018 | 362 | 0.040 |
Why?
| | Sex Distribution | 1 | 2018 | 351 | 0.040 |
Why?
| | Neurons | 1 | 2005 | 1345 | 0.040 |
Why?
| | Prosthesis Failure | 1 | 2018 | 120 | 0.040 |
Why?
| | Risk | 1 | 2020 | 853 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2006 | 4596 | 0.040 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2016 | 15 | 0.040 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 187 | 0.040 |
Why?
| | Thoracoscopy | 1 | 2017 | 58 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 526 | 0.040 |
Why?
| | Galectin 3 | 1 | 2016 | 20 | 0.040 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2016 | 56 | 0.040 |
Why?
| | Prednisone | 1 | 2017 | 235 | 0.040 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2017 | 333 | 0.040 |
Why?
| | Genetic Markers | 1 | 2017 | 348 | 0.040 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2017 | 112 | 0.040 |
Why?
| | Methotrexate | 1 | 2017 | 227 | 0.040 |
Why?
| | Prosthesis Design | 1 | 2018 | 285 | 0.040 |
Why?
| | Neoplasms | 1 | 2010 | 2179 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 272 | 0.030 |
Why?
| | Heart | 1 | 2020 | 631 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 454 | 0.030 |
Why?
| | Radiography | 1 | 2018 | 861 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 806 | 0.030 |
Why?
| | Disease Progression | 2 | 2019 | 2490 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2020 | 472 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 765 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2015 | 100 | 0.030 |
Why?
| | United States | 3 | 2018 | 12555 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2015 | 280 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 690 | 0.030 |
Why?
| | North America | 1 | 2015 | 266 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 113 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 521 | 0.030 |
Why?
| | Luminescent Proteins | 1 | 2015 | 174 | 0.030 |
Why?
| | Elastin | 1 | 2014 | 77 | 0.030 |
Why?
| | Stents | 1 | 2018 | 457 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1435 | 0.030 |
Why?
| | Pancreatectomy | 1 | 2015 | 165 | 0.030 |
Why?
| | Regeneration | 1 | 2015 | 165 | 0.030 |
Why?
| | Retreatment | 1 | 2013 | 71 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 111 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 220 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 200 | 0.030 |
Why?
| | Cohort Studies | 2 | 2018 | 5116 | 0.030 |
Why?
| | Nitric Oxide | 1 | 2019 | 892 | 0.030 |
Why?
| | Gene Order | 1 | 2013 | 28 | 0.030 |
Why?
| | Albumins | 1 | 2013 | 100 | 0.030 |
Why?
| | Liver Failure, Acute | 1 | 2013 | 63 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 105 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1231 | 0.030 |
Why?
| | Autoimmunity | 1 | 2019 | 831 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2017 | 545 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 157 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1636 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2013 | 121 | 0.030 |
Why?
| | Radiation Dosage | 1 | 2013 | 147 | 0.030 |
Why?
| | Gene Dosage | 1 | 2013 | 136 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2013 | 336 | 0.030 |
Why?
| | Collagen | 1 | 2014 | 433 | 0.030 |
Why?
| | Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 3 | 0.030 |
Why?
| | Phenyl Ethers | 1 | 2011 | 3 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2016 | 980 | 0.030 |
Why?
| | Wilms Tumor | 1 | 2013 | 69 | 0.030 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 2011 | 24 | 0.030 |
Why?
| | S100 Proteins | 1 | 2011 | 35 | 0.030 |
Why?
| | Prevalence | 1 | 2018 | 2326 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2013 | 510 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 2851 | 0.030 |
Why?
| | Hemagglutinins | 1 | 2011 | 11 | 0.030 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 68 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2013 | 253 | 0.030 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2012 | 109 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2012 | 153 | 0.020 |
Why?
| | Isoantibodies | 1 | 2011 | 63 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2014 | 446 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2012 | 244 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2010 | 52 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1158 | 0.020 |
Why?
| | Radiosurgery | 1 | 2013 | 318 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 1901 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1419 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2025 | 0.020 |
Why?
| | Shock, Septic | 1 | 2012 | 187 | 0.020 |
Why?
| | HLA Antigens | 1 | 2011 | 230 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2003 | 2220 | 0.020 |
Why?
| | Graft vs Host Disease | 1 | 2012 | 216 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1882 | 0.020 |
Why?
| | Arthralgia | 1 | 2010 | 51 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 4908 | 0.020 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2015 | 451 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 934 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 963 | 0.020 |
Why?
| | Monocytes | 1 | 2012 | 513 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2071 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2871 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 544 | 0.020 |
Why?
| | Endocrine System Diseases | 1 | 2007 | 32 | 0.020 |
Why?
| | Growth Disorders | 1 | 2007 | 77 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 2007 | 98 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2007 | 125 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 6471 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2007 | 211 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 1900 | 0.020 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 709 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 2007 | 261 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2445 | 0.020 |
Why?
| | Chromosomes, Human, Pair 13 | 1 | 2002 | 18 | 0.010 |
Why?
| | Purpura | 1 | 2002 | 12 | 0.010 |
Why?
| | Karyotyping | 1 | 2002 | 102 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2002 | 72 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 2002 | 154 | 0.010 |
Why?
| | Hyperplasia | 1 | 2002 | 170 | 0.010 |
Why?
| | Bone Marrow | 1 | 2002 | 255 | 0.010 |
Why?
| | Thrombocytopenia | 1 | 2002 | 185 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2002 | 1012 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2010 | 3174 | 0.010 |
Why?
| | RNA, Viral | 1 | 2002 | 572 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2002 | 1085 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2002 | 2235 | 0.010 |
Why?
|
|
Galambos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|